LBA54 Randomized phase III trial of nivolumab in...

Annals of Oncology 2020 / 09 Vol. 31

LBA54 Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC

Lee, J-S., Sugawara, S., Kang, J.H., Kim, H.R., Inui, N., Hida, T., Lee, K.H., Yoshida, T., Tanaka, H., Yang, C.T., Nishio, M., Ohe, Y., Tamura, T., Yamamoto, N., Yu, C-J., Akamatsu, H., Namba, Y., Su
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.2287
Date:
September, 2020
File:
PDF, 96 KB
2020
Conversion to is in progress
Conversion to is failed